Outlook Therapeutics (OTLK)
NASDAQ:OTLK
Holding OTLK?
Track your performance easily

Outlook Therapeutics (OTLK) Cash flow

1,175 Followers

Outlook Therapeutics Cash Flow

OTLK's free cash flow for Q3 2024 was $-19.51M. For the 2024 fiscal year, OTLK's free cash flow was decreased by $13.70M and operating cash flow was $-19.51M. See a summary of the company’s cash flow.
Cash Flow
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Operating Cash Flow
$ -64.55M$ -42.97M$ -56.67M$ -54.25M$ -31.79M$ -32.29M
Investing Cash Flow
----$ -900.00K$ -437.31K
Financing Cash Flow
$ 62.87M$ 48.97M$ 59.59M$ 56.19M$ 37.21M$ 39.03M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 113.00M$ 23.39M$ 17.40M$ 14.48M$ 12.54M$ 8.02M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 476.00K$ 1.40K$ 1.56M$ 46.24K$ 913.97K$ 2.79M
Issuance Of Capital Stock
$ 62.88M$ 30.02M$ 62.31M$ 46.30M$ 35.43M$ 45.96M
Issuance Of Debt
$ -7.35K$ 19.77M$ -2.32M$ 6.30M$ 640.92K$ -6.94M
Repayment Of Debt
$ -6.26K$ -10.23M$ -12.32M$ -3.70M$ -263.28K$ -6.94M
Free Cash Flow
$ -45.29M$ -42.97M$ -56.67M$ -54.25M$ -31.79M$ -32.73M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Outlook Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis